Abiopharma

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Blackstone Closes Flagship Opportunistic Credit Fund at Over $10B, Hitting Hard Cap

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

Aris Mining Reports Q1 2026 Production and Strong Revenue Growth

Tradeweb Reports Record March 2026 Total Trading Volume of $87.0 Trillion and Record Average Daily Volume of $3.8 Trillion

Akamai Technologies To Hold First Quarter 2026 Investor Conference Call On Thursday, May 7, at 4:30 PM ET

Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales

PAR Technology Announces PAR Intelligence: Establishing the Agentic OS for Multi-Unit Operators

Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

Randy Anaya Brings 65-Agent Equity Realty Group to The Real Brokerage

Bread Financial Schedules First Quarter 2026 Earnings Conference Call for Apr. 23

Creative Realities, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information

CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

NOVO NORDISK A S (NVO) Files Form 6-K